米杰治疗膜性肾病经验  被引量:1

Experience of Professor MI Jie in Treating Membranous Nephropathy

在线阅读下载全文

作  者:苏珊珊[1] 刘慧[1] 修方睿 王冬燕[1] SU Shanshan;LIU Hui;XIU Fangrui;WANG Dongyan(The Affiliated Hospital of Shandong University of Traditional Chinese Medicine,Jinan 250011,China)

机构地区:[1]山东中医药大学附属医院,山东济南250011

出  处:《山东中医杂志》2022年第7期782-786,共5页Shandong Journal of Traditional Chinese Medicine

基  金:齐鲁医派中医药特色技术整理推广项目(批文号:鲁卫函〔2022〕93号)。

摘  要:膜性肾病属中医学水肿范畴,米杰教授认为本病病因责之外邪袭表、饮食不节、久病劳倦及药物或毒物损伤;病机总属本虚标实、虚实夹杂,以脾肾亏虚为本,湿瘀互结为标。临床治疗时注重辨病、辨证、辨体质合参,首辨标本,主张从虚、从湿、从瘀分型论治,同时配合以外治法及生活调摄。经过长期临证应用,在提高缓解率、减少复发、延缓肾功能下降、减轻激素及免疫抑制剂不良反应方面取得良效。Membranous nephropathy(MN)pertains to the category of edema in traditional Chinese medicine.According to Professor MI Jie,the disease causes of MN are invasion of external evil,improper diet,chronic disease and fatigue,and injury by drugs or toxins,and the disease mechanism is root deficiency and branch excess,mixed deficiency and excess,in which spleen and kidney deficiency is the root,while intermingled dampness and stasis is the branch.In clinical treatment,disease differentiation,syndrome differentiation and constitution differentiation should be conducted in combination to first determine the root and branch.Professor MI advocates to differentiate and treat MN from deficiency,dampness and stasis and combines with external therapy and healthy cultivation.After long-term clinical application,such treatment has achieved good results in improving the remission rate,reducing recurrence,delaying the decline of renal function,and reducing the adverse reactions caused by hormones and immunosuppressants.

关 键 词:膜性肾病 本虚标实 脾肾亏虚 湿瘀互结 辨病辨证辨体结合 米杰 

分 类 号:R256.51[医药卫生—中医内科学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象